| Home | E-Submission | Sitemap | Editorial Office |  
top_img
Clinical and Molecular Hepatology Search > Browse Articles > Search



Discussion on critical points for a tailored therapy to cure hepatitis C virus infection
Nadia Marascio, Angela Quirino, Giorgio Settimo Barreca, Luisa Galati, Chiara Costa, Vincenzo Pisani, Maria Mazzitelli, Giovanni Matera, Maria Carla Liberto, Alfredo Focà, Carlo Torti
Clin Mol Hepatol.2019;25(1):30-36.   Published online January 23, 2019     
DOI: https://doi.org/10.3350/cmh.2018.0061
                              
Recent update of the 2017 Korean Association for the Study of the Liver (KASL) treatment guidelines of chronic hepatitis C: Comparison of guidelines from other continents, 2017 AASLD/IDSA and 2016 EASL
Jong Eun Yeon
Clin Mol Hepatol.2018;24(3):278-293.   Published online May 2, 2018     
DOI: https://doi.org/10.3350/cmh.2018.1002
                                 Cited By 1
Clinical characteristics of patients with chronic hepatitis B who developed genotypic resistance to entecavir: Real-life experience
Hong Joo Kim, Yong Kyun Cho, Woo Kyu Jeon, Byung Ik Kim
Clin Mol Hepatol.2017;23(4):323-330.   Published online September 5, 2017     
DOI: https://doi.org/10.3350/cmh.2017.0005
                                 Cited By 3
Is it possible to predict the development of an entecavir resistance mutation in patients with chronic hepatitis B in clinical practice?
Joon Yeul Nam, Jeong-Hoon Lee
Clin Mol Hepatol.2017;23(4):311-313.   Published online December 4, 2017     
DOI: https://doi.org/10.3350/cmh.2017.0069
                              
Efficacy of tenofovir-based rescue therapy for chronic hepatitis B patients with resistance to lamivudine and entecavir
Hee-Jeong Jeon, Seok Won Jung, Neung Hwa Park, Yujin Yang, Jin-Hee Noh, Jae-Sung Ahn, Hyung Rae Kim, Jae Ho Lee, Jung Woo Shin
Clin Mol Hepatol.2017;23(3):230-238.   Published online June 30, 2017     
DOI: https://doi.org/10.3350/cmh.2017.0003
                                 Cited By 4
Is tenofovir monotherapy a sufficient defense line against multi-drug resistant hepatitis B virus?
Yun Bin Lee, Jeong-Hoon Lee
Clin Mol Hepatol.2017;23(3):219-221.   Published online September 19, 2017     
DOI: https://doi.org/10.3350/cmh.2017.0045
                              
Switch to tenofovir-based therapy or to continue adefovir-based therapy in CHB patients with suboptimal response to adefovir-based combination?
Byung-Cheol Song
Clin Mol Hepatol.2016;22(4):439-442.   Published online December 25, 2016     
DOI: https://doi.org/10.3350/cmh.2016.0108
                              
The efficacy of tenofovir-based therapy in patients showing suboptimal response to entecavir-adefovir combination therapy
Jeong Han Kim, Sung Hyun Ahn, Soon Young Ko, Won Hyeok Choe, Kyun-Hwan Kim, So Young Kwon
Clin Mol Hepatol.2016;22(2):241-249.   Published online June 15, 2016     
DOI: https://doi.org/10.3350/cmh.2015.0053
                                 Cited By 3
Is the tenofovir based therapy almighty for previous treatment failure in chronic hepatitis B?
Hyung Joon Yim
Clin Mol Hepatol.2016;22(2):238-240.   Published online June 25, 2016     
DOI: https://doi.org/10.3350/cmh.2016.0103
                                 Cited By 1
Comparison of tenofovir plus lamivudine versus tenofovir monotherapy in patients with lamivudine-resistant chronic hepatitis B
Chan Ho Park, Seok Won Jung, Jung Woo Shin, Mi Ae Bae, Yoon Im Lee, Yong Tae Park, Hwa Sik Chung, Neung Hwa Park
Clin Mol Hepatol.2016;22(1):152-159.   Published online March 28, 2016     
DOI: https://doi.org/10.3350/cmh.2016.22.1.152
                              
Entecavir plus tenofovir versus entecavir plus adefovir in chronic hepatitis B patients with a suboptimal response to lamivudine and adefovir combination therapy
Jung Gil Park, Soo Young Park
Clin Mol Hepatol.2015;21(3):242-248.   Published online September 30, 2015     
DOI: https://doi.org/10.3350/cmh.2015.21.3.242
                                 Cited By 1
Impact of prior lamivudine use on the antiviral efficacy and development of resistance to entecavir in chronic hepatitis B patients
Joo An Hwang, Kee Bum Kim, Min Jae Yang, Sun Gyo Lim, Jae Chul Hwang, Jae Youn Cheong, Sung Won Cho, Soon Sun Kim
Clin Mol Hepatol.2015;21(2):131-140.   Published online June 26, 2015     
DOI: https://doi.org/10.3350/cmh.2015.21.2.131
                                 Cited By 2
Hepatitis B surface antigen levels at 6 months after treatment can predict the efficacy of lamivudine-adefovir combination therapy in patients with lamivudine-resistant chronic hepatitis B
Jeong Han Kim, Hee Won Moon, Soon Young Ko, Won Hyeok Choe, So Young Kwon
Clin Mol Hepatol.2014;20(3):274-282.   Published online September 25, 2014     
DOI: https://doi.org/10.3350/cmh.2014.20.3.274
                                 Cited By 1
Long-term outcomes of two rescue therapies in lamivudine-refractory patients with chronic hepatitis B: combined lamivudine and adefovir, and 1-mg entecavir
EunYoung Ze, Eun Kyung Baek, Jong Jin Lee, Han Wook Chung, Dae Geon Ahn, Hwan Jun Cho, Jae Cheol Kwon, Hyung Joon Kim, HyunWoong Lee
Clin Mol Hepatol.2014;20(3):267-273.   Published online September 25, 2014     
DOI: https://doi.org/10.3350/cmh.2014.20.3.267
                                 Cited By 5
The impact of pegylated interferon and ribavirin combination treatment on lipid metabolism and insulin resistance in chronic hepatitis C patients
Hee Jae Jung, Young Seok Kim, Sang Gyune Kim, Yun Nah Lee, Soung Won Jeong, Jae Young Jang, Sae Hwan Lee, Hong Soo Kim, Boo Sung Kim
Clin Mol Hepatol.2014;20(1):38-46.   Published online March 26, 2014     
DOI: https://doi.org/10.3350/cmh.2014.20.1.38
                                 Cited By 24
HBsAg level and clinical course in patients with chronic hepatitis B treated with nucleoside analogue: five years of follow-up data
Jeong Han Kim, Yun Jung Choi, Hee Won Moon, Soon Young Ko, Won Hyeok Choe, So Young Kwon
Clin Mol Hepatol.2013;19(4):409-416.   Published online December 28, 2013     
DOI: https://doi.org/10.3350/cmh.2013.19.4.409
                                 Cited By 4
Performance evaluation of the HepB Typer-Entecavir kit for detection of entecavir resistance mutations in chronic hepatitis B
Sang Hoon Ahn, Ji-Yong Chun, Soo-Kyung Shin, Jun Yong Park, Wangdon Yoo, Sun Pyo Hong, Soo-Ok Kim, Kwang-Hyub Han
Clin Mol Hepatol.2013;19(4):399-408.   Published online December 28, 2013     
DOI: https://doi.org/10.3350/cmh.2013.19.4.399
                              Supplementary      
Lamivudine plus adefovir combination therapy for lamivudine resistance in hepatitis-B-related hepatocellular carcinoma patients
Jeong Han Kim, Soon Young Ko, Won Hyeok Choe, So Young Kwon, Chang Hong Lee
Clin Mol Hepatol.2013;19(3):273-279.   Published online September 30, 2013     
DOI: https://doi.org/10.3350/cmh.2013.19.3.273
                                 Cited By 1
Options for the management of antiviral resistance during hepatitis B therapy: reflections on battles over a decade
Hyung Joon Yim, Seong Gyu Hwang
Clin Mol Hepatol.2013;19(3):195-209.   Published online September 30, 2013     
DOI: https://doi.org/10.3350/cmh.2013.19.3.195
                                 Cited By 17
The influence of waist circumference on insulin resistance and nonalcoholic fatty liver disease in apparently healthy Korean adults
Deok Yun Ju, Young Gil Choe, Yong Kyun Cho, Dong Suk Shin, Su Hyeon Yoo, Seo Hyoung Yim, Ji Yong Lee, Jung Ho Park, Hong Joo Kim, Dong Il Park, Chong Il Sohn, Woo Kyu Jeon, Byung Ik Kim
Clin Mol Hepatol.2013;19(2):140-147.   Published online June 27, 2013     
DOI: https://doi.org/10.3350/cmh.2013.19.2.140
                                 Cited By 7
Antiviral efficacies of currently available rescue therapies for multidrug-resistant chronic hepatitis B
Mi Sung Park, Beom Kyung Kim, Kyung Sik Kim, Ja Kyung Kim, Seung Up Kim, Jun Yong Park, Do Young Kim, Oidov Baartarkhuu, Kwang Hyub Han, Chae Yoon Chon, Sang Hoon Ahn
Clin Mol Hepatol.2013;19(1):29-35.   Published online March 25, 2013     
DOI: https://doi.org/10.3350/cmh.2013.19.1.29
                                 Cited By 9
High efficacy of adefovir and entecavir combination therapy in patients with nucleoside-refractory hepatitis B
Hee Bok Chae, Mee Jin Kim, Eui Geun Seo, Yong Hyeok Choi, Hee Seung Lee, Joung Ho Han, Soon Man Yoon, Seon Mee Park, Sei Jin Youn
Korean J Hepatol.2012;18(1):75-83.   Published online March 22, 2012     
DOI: https://doi.org/10.3350/kjhep.2012.18.1.75
                                 Cited By 11
Hemodynamic alterations in cirrhosis and portal hypertension
Moon Young Kim, Soon Koo Baik, Samuel S. Lee
Korean J Hepatol.2010;16(4):347-352.   Published online December 31, 2010     
DOI: https://doi.org/10.3350/kjhep.2010.16.4.347
                                 Cited By 42
Forty-eight weeks treatment with clevudine 30 mg qd versus lamivudine 100 mg qd for chronic hepatitis B infection: a double-blind randomized study
George KK Lau, Nancy Leung
Korean J Hepatol.2010;16(3):315-320.   Published online September 30, 2010     
DOI: https://doi.org/10.3350/kjhep.2010.16.3.315
                                 Cited By 9
Genotypic resistance to entecavir in chronic hepatitis B patients
Byeong Uk Kim, M.D., Ja Chung Goo, M.D., Byeong Chul Park, M.D., Soo Ok Kim, Ph.D.1, Sun Pyo Hong, Ph.D.1, Jee In Jeong, M.D., Hee Bok Chae, M.D., Seon Mee Park, M.D., Sei Jin Youn, M.D.
Korean J Hepatol.2010;16(2):147-157.   Published online June 25, 2010     
DOI: https://doi.org/10.3350/kjhep.2010.16.2.147
         Cited By 2
Efficacy and predictors of the virologic response to entecavir therapy in nucleoside naive patients with chronic hepatitis B
Hyung-Joon Myung, M.D., Sook-Hyang Jeong, M.D., Jin-Wook Kim, M.D., Hee-Sup Kim, M.D., Je-Hyuck Jang, M.D., Dong Ho Lee, M.D., Nayoung Kim, M.D., Jin-Hyeok Hwang, M.D., Young Soo Park, M.D., Sang-Hyub Lee, M.D.
Korean J Hepatol.2010;16(1):57-65.   Published online March 26, 2010     
DOI: https://doi.org/10.3350/kjhep.2010.16.1.57
         Cited By 8
Efficacy of 48-week clevudine therapy for chronic hepatitis B
Min Hwan Kim, M.D., Kyung-Ah Kim, M.D., June Sung Lee, M.D., Hyun Woong Lee, M.D.1, Hyung Joon Kim, M.D.1, Sang Gu Yun, M.D., Nam-Hoon Kim, M.D., Won Ki Bae, M.D., Young Soo Moon, M.D.
Korean J Hepatol.2009;15(3):331-337.   Published online September 30, 2009     
DOI: https://doi.org/10.3350/kjhep.2009.15.3.331
         Cited By 8
Long-term clevudine therapy in nucleos(t)ide-naive and Lamivudine-experienced patients with hepatitis B virus-related chronic Liver diseases
Heon Ju Lee, M.D., Jong Ryul Eun, M.D., Chang Hyeong Lee, M.D.1, Jae Seok Hwang, M.D.2, Jeong Ill Suh, M.D.3, Byung Seok Kim, M.D.1, Byoung Kuk Jang, M.D.2 Departments of
Korean J Hepatol.2009;15(2):179-192.   Published online June 30, 2009     
DOI: https://doi.org/10.3350/kjhep.2009.15.2.179
         Cited By 12
Clevudine therapy in patients with chronic hepatitis B
Kwan Sik Lee
Korean J Hepatol.2009;15(2):119-121.   Published online June 30, 2009     
DOI: https://doi.org/10.3350/kjhep.2009.15.2.119
         Cited By 2
Virologic response to adefovir dipivoxil monotherapy is not durable in HBeAg-positive, Lamivudine-resistant chronic hepatitis B patients
Hyun Wook Jung , Moon Seok Choi , Kap Hyun Kim , Sung Hyun Park , Keum Yeon Kwak , Joon Hyoek Lee , Kwang Cheol Koh , Seung Woon Paik , Byung Chul Yoo
Korean J Hepatol.2009;15(1):52-58.   Published online March 31, 2009     
DOI: https://doi.org/10.3350/kjhep.2009.15.1.52
      
1 | 2 |
E-Submission
Email Alert
Author's Index
EndNote Style file download
The Korean Association for the Study of the Liver
The Liver Week 2019
SCImago Journal & Country Rank
PubMed Central
PubMed
Scopus
KoreaMed
KoMCI
ScienceCentral
DOAJ
GoogleScholar
Similarity Check
Crossref Cited-by Linking
CrossMark
Funder Registry
ORCID
MeSH on Demand
COPE
Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: kasl@kams.or.kr
About |  Browse Articles |  Current Issue |  For Authors and Reviewers
Copyright © The Korean Association for the Study of the Liver. All rights reserved.         
COUNTER
TODAY : 295
TOTAL : 230177